Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „emtricitabine“
Suchtreffer
Begriffe & Kennungen
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir: AUC: ↑ 81% (↑ 68 to ↑ 94) Cmax: ↑ 77% (↑ 53 to ↑ 104) Cmin: ↑ 121% (↑ 100 to ↑ 143) Sofosbuvir/Velp
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir: AUC: ↑ 98% (↑ 77 to ↑ 123) Cmax: ↑ 79% (↑ 56 to ↑ 104) Cmin: ↑ 163% (↑ 137 to ↑ 197) Sofosbuvir/Vel
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir: AUC: ↓ 10% C12h: ↓ 13% Cmax: ↓ 23% Raltegravir/Emtricitabine Interaction not studied. NRTIs and NNR
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 25% (↑ 8 to ↑ 45) Cmin: ↔ Antibiotics Clarithromycin/Efavirenz Clarithromycin: The c
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir: AUC: ↔ Cmax: ↔ Lopinavir/ritonavir/Tenofovir Lopinavir/Ritonavir: Insufficient data are available t
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir: AUC: ↔ Cmax: ↔ Norgestimate/Ethinyloestradiol/ Interaction not studied. Emtricitabine Injection: In
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · There were no clinically significant pharmacokinetic interactions when efavirenz was administered with azithro
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · There were no clinically significant pharmacokinetic interactions when emtricitabine was administered with sta
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Total active HMG Co-A reductase inhibitors: AUC: ↓ 34% (↓ 21 to ↓ 41) Cmax: ↓ 20% (↓ 2 to ↓ 26) Atorvastatin/E
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Use of efavirenz/emtricitabine/tenofovir disoproxil should be avoided with concurrent or recent use of a nephr
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Voriconazole Co-administration of standard doses of efavirenz and voriconazole is contraindicated. Since efavi
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · When efavirenz was given with ritonavir 500 mg or 600 mg twice daily, the combination was not well tolerated (
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 Undesirable effects · 1
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · 27 Severe skin reactions such as Stevens-Johnson syndrome and erythema multiforme; neuropsychiatric adverse re
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · 28 Efavirenz Emtricitabine Tenofovir disoproxil Very common hypophosphataemia2 Common hypertriglyceridaemia3 h
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · 29 Efavirenz Emtricitabine Tenofovir disoproxil Uncommon hepatitis acute Rare hepatic failure3,4 hepatic steat
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · 30 Rash In clinical studies of efavirenz, rashes were usually mild-to-moderate maculopapular skin eruptions th
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · Adverse reactions associated with the use of efavirenz/emtricitabine/tenofovir disoproxil Treatment-emergent a
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · Common: - anorexia
Eintrag öffnen